the patient numbers may be insufficient to confer any statistical significant. We know Bis anti-cancer response is dose dependent however P1A will be very restrictive. In terms of cardio protection ratio of Bis to Dox is also relevant. Anticipating the we may get some insights but the cohort size for the optimal ratio / dose will be small limiting any meaningful conclusion.
The above doesn’t stop us reading between the lines : )
RAC Price at posting:
$1.47 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)